Global Enteral Syringe Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
“Global Enteral Syringe Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz. The global enteral syringe market report has been segmented on the basis of product type, application, patient group, end user, and region.
Global Enteral Syringe Market: Overview
Enteral syringes are majorly used for administrating drugs and nutritional therapy through oral, rectal or sublingual route of patients that are admitted in NICU, hospital, and critical care unit. Enteral syringes are commonly used in clinics, hospitals, and homes and available in range of 1ml to 60 ml. Newly launched enteral syringes are manufactured to meet international standard ISO-80369-3. Enteral syringes are widely used in order to deliver oral liquid medication. These syringes are come with purple plunger which denotes that the medication in syringe administered via enteral route. Purple color is used to differentiate these syringes from IV syringes. Enteral syringes are available in different types – single use syringes, home use syringes, reusable enteral syringes.
Global Enteral Syringe Market: Dynamics
Increasing incidence of chronic diseases such as cancer, which resulting in hospitalization in late stage of disease. Patients are not able to digest food and medicines, they required enteral syringes in such circumstances which is a major factor expected to drive growth of the global market over the forecast period.
In addition, rising number of admissions to NICU, prevalence of chronic diseases, and increasing geriatric population globally are expected to further fuel growth of the target market over the forecast period.
Innovative product launches and increasing research and development activates for development of new products are expected to create potential revenue opportunities for players operating in the target market over the forecast period.
Global Enteral Syringe Market: Segment Analysis
On the basis of product type, the single use enteral syringes segment is expected to register significant growth in terms of revenue over the forecast period, owing to increasing number of ICU admissions, nutritional deficiency amongst these patients, and adoption of enteral syringes. On the basis of application, the oncology segment is expected to register significant share in terms of revenue over the forecast period, owing to increasing incidence of cancer across the globe. On the basis of patient group, the adults segment is expected to dominate the global market during the forecast period. On the basis of end user, the hospitals and ambulatory care centers segment is expected to register significant growth in the near future.
Global Enteral Syringe Market: Regional Analysis
The market in North America is expected dominate the global market in terms of revenue over the forecast period, followed by Europe and Asia Pacific. Increasing incidence rate of chronic diseases such as neurological disorder, cancer, and rising number of hospital admissions regarding this type of disease in the US. The market in Asia Pacific is expected to register significant growth in terms of revenue over the forecast period, owing to increasing incidence of premature birth and weak newborns which needs enteral feeding after birth. Moreover, rising awareness of enteral nutrition and improving healthcare facilities across emerging economies across this region.
Global Enteral Syringe Market Segmentation:
Segmentation by product type:
- Single Use Enteral Syringes
- Home Use Enteral Syringes
- Catheter Tip Syringes
Segmentation by application:
- Neurological Disease
- GI Related Disease
- Others (Diabetes, Hypermetabolism)
Segmentation by patient group:
- Neonates and Pediatrics
Segmentation by end user:
- Hospitals and Ambulatory care centers
- Home-based user
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Braun Melsungen AG
- Thermo Fisher Scientific Inc.
- Gbuk Enteral Limited
- Baxter International, Inc.
- Vygon S.A.
- Koninklijke Philips N.V.
- Cardinal Health, Inc.
- Terumo Corporation
- Fresenius Kabi AG
- Halyard Health, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!